Diagnos Laboratorium Utama Tbk. vs Kioson Komersial Indonesia Tbk — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B, 27.5K 24h volume), while Kioson Komersial Indonesia Tbk trades at Rp92 (market cap 100.06B, 30.53M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 3.1× Kioson Komersial Indonesia Tbk's market cap, and Kioson Komersial Indonesia Tbk is more actively traded (30.53M versus 27.5K). Which is the better fit depends on your goals.
| DGNS | KIOS | |
|---|---|---|
Market Cap | 308B | 100.06B |
Volume | 27.5K | 30.53M |
Lot | 275 | 305.26K |
Turnover | 6.23M | 2.85B |
Average Price | 226.59 | 93.46 |
Value | 6.23M | 2.85B |
Indicative Equilibrium Price | 230 | 93 |
Indicative Equilibrium Volume | 110 | 137.7K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Kioson Komersial Indonesia Tbk (the Company), was established on June 29, 2015 based on Notarial Deed No. 55 of Rose Takarina, S.H.
Read more on KIOS →